Patients With BRAFV600 E or BRAFV600K Mutation
1 clinical trials · Condition
◉ Watch Patients With BRAFV600 E or BRAFV600K Mutation
| Record | Firm | Date |
|---|---|---|
| BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA) (NCT02834364) | University of Heidelberg Medical Center | 2016-06-01 |
Track Patients With BRAFV600 E or BRAFV600K Mutation automatically
Every clearance here is in the API, with alerts when new ones post.